US Foods (USFD) Q2 2026 earnings review
Volume Accelerates and Margins Expand Despite Macro Headwinds
US Foods delivered a highly robust Q2, proving its 'self-help' strategy is working. Net sales grew 4.5% to $10.5 billion, and Adjusted EBITDA jumped 10.2% to a record $604 million. The core story is the continued, accelerating success in the Independent Restaurant segment, which grew case volume by 5.1%—its fastest pace in years. While the chain restaurant business remains a stubborn drag, the company's ability to drive 29 basis points of Adjusted EBITDA margin expansion in a sluggish consumer environment demonstrates strong operational control. Full-year guidance was reaffirmed, keeping the company squarely on track with its long-range algorithm.
🐂 Bull Case
Independent restaurant case volume growth accelerated to 5.1%. This high-margin segment is driving overall volume up 1.9% and insulating US Foods from broader industry traffic weakness.
Gross profit increased 8.0%, significantly outpacing the 4.5% net sales growth. Adjusted EBITDA margin expanded 29 basis points to 5.7%, proving that internal productivity and vendor management initiatives are yielding tangible results.
🐻 Bear Case
Chain volume declined 1.5%. While improving sequentially, the segment has contracted for multiple consecutive quarters, dragging down total top-line potential.
Despite Net Income growing 15.3% in the first half of the year, Operating Cash Flow was completely flat at $725 million due to a sharp $299 million increase in receivables.
⚖️ Verdict: 🟢
Bullish. Accelerating volume in the most profitable segments coupled with record EBITDA margins proves management is executing flawlessly on the variables they can control, overpowering the weak macro environment.
Key Themes
Independent Restaurant Growth Accelerating
The strategic focus on Independent Restaurants is paying massive dividends. Case volume growth in this segment has systematically accelerated from 2.7% in 25Q2 to 5.1% in 26Q2. This growth mix is highly favorable, as independent accounts typically adopt more private label products and utilize value-added tech tools, driving outsized gross profit.
Targeted Customer Segments Outperforming
Beyond independents, the Healthcare and Hospitality segments remain robust growth engines. Healthcare volume increased 3.5% and Hospitality increased 4.4% in 26Q2. These targeted channels provide defensive stability and are actively responding to targeted programs like the 'Signature' hospitality suite.
Margin Expansion via Productivity
Operating expenses grew 5.1%, lagging the 8.0% growth in gross profit. Adjusted operating expenses as a percentage of net sales dropped to 12.5%. Management's 'self-help' initiatives—including the Descartes routing rollout, UMOS warehouse productivity, and strategic vendor management—are successfully neutralizing inflation and driving leverage.
Chain Volume Trajectory
Chain restaurant volume remained negative at -1.5%. While this is a sequential improvement from -2.3% in Q1 and -3.4% in 25Q4, the segment is consistently bleeding volume. Management must decide whether this is acceptable attrition or if corrective pricing/promotional action is required.
Working Capital Eating Cash Flow Growth
A clear contradiction to the glowing earnings report is found in the cash flow statement. Year-to-date Net Income grew 15.3% to $391 million, but Operating Cash Flow remained totally flat at $725 million. This was driven by a $299 million increase in receivables (compared to a $230 million increase last year), suggesting customers might be stretching payment terms in a tough macro environment.
Macro and Consumer Traffic Backdrop
Despite excellent company-specific execution, the broader macroeconomic picture remains challenging. Industry restaurant foot traffic continues to trend negative, creating a permanent headwind. US Foods is outgrowing the market by taking share, but a protracted consumer recession could eventually compress their target 5-8% independent growth ceiling.
Other KPIs
Accelerating. Grew 8.0% YoY, outpacing the 4.5% top-line growth. This reflects strong cost-of-goods-sold management and higher volume, bolstered by a $19 million favorable LIFO adjustment.
Accelerating significantly. The company aggressively bought back 4.4 million shares in Q2 alone, bringing the first-half total to $500 million. This leaves $640 million remaining on the November 2025 authorization, actively boosting Adjusted EPS.
Stable. The ratio sits comfortably within the company's 2.0x - 3.0x target range, improving slightly from 2.7x at the end of FY25 despite heavy cash deployments for buybacks.
Guidance
Stable. Reaffirmed from prior guidance. This includes approximately a 1% expected benefit from the 53rd operating week in Fiscal 2026. The Q2 actual result of 4.5% places the company comfortably on track.
Stable. Reaffirmed range. This incorporates a ~1% boost from the 53rd week. Q2's 10.2% growth proves execution is matching the long-range plan algorithm.
Stable. Reaffirmed range. Q2 printed at 21.0%, sitting right at the midpoint. Aggressive share repurchases in H1 ($500M) virtually guarantee the company will hit or exceed this target assuming operating conditions remain steady.
Key Questions
Receivables and Credit Quality
Operating cash flow was flat YoY despite a 15% increase in Net Income, dragged down by a $299M build in receivables. Are independent restaurants stretching payment terms, and are you seeing any deterioration in bad debt provisions?
Chain Strategy
Chain volumes have contracted for multiple quarters. Is this intentional pruning of low-margin business, or are you losing RFPs to competitors? What is the floor for this segment?
Capital Allocation Pace
You repurchased $374M of stock in Q2 alone. Should we expect this accelerated pace to normalize in H2, or is this the new run-rate given the strength of the balance sheet?
Variable Comp Plan Rollout
The new 100% variable sales compensation plan went live this quarter. Have there been any localized disruptions or elevated turnover, or has the transition been entirely seamless?